Emre Ozkumur, is Vice President of Research and Development at AutoIVF, where he leads core technology development and clinical translation for the OvaReady platform. He established AutoIVF’s R&D roadmap and secured multiple NIH SBIR Phase I and Phase II awards to support development and clinical testing of the microfluidic platforms. Most recently, Emre was a founding team member and Program Manager at MicroMedicine, where he supported early-stage technology development and feasibility programs for a microfluidic Class I diagnostic platform, bridging discovery research with downstream product and manufacturing teams. Earlier, he served as a Senior Scientist at Massachusetts General Hospital and Harvard Medical School, where he led applied cancer cell isolation research within a large industry–academic collaboration and helped expand multi-center clinical research adoption. Education: MS and PhD in Electrical Engineering from Boston University; dual BS degrees in Electrical and Electronics Engineering and Physics from Koç University.